Teladoc Health, Inc. (TDOC)
| Market Cap | 28.97B |
| Revenue (ttm) | 1.09B |
| Net Income (ttm) | -485.14M |
| Shares Out | 90.51M |
| EPS (ttm) | -5.36 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 5 |
| Last Price | $189.69 |
| Previous Close | $195.98 |
| Change ($) | -6.29 |
| Change (%) | -3.21% |
| Day's Open | 194.15 |
| Day's Range | 174.00 - 197.71 |
| Day's Volume | 8,593,196 |
| 52-Week Range | 102.01 - 308.00 |
The market has crushed growth stocks today.
Yields are on the rise and valuation-propelled tech is getting deflated.
ARK Invest buys this week have some stocks taking off as the private investment firm picks up shares on the stock market dip. The post ARK Invest Buys: What Stocks Is Cathie Wood Buying on the...
Management predicted robust revenue growth for 2021, but guidance for membership increases fell short of heightened hopes.
These stocks have benefited greatly from the work-from-home trend, but questions about a post-pandemic world might not point to longevity. The post 7 Stocks That Could Crash if Work From Home ...
Last month wasn't a good one for these stocks, but there is plenty of reason to remain bullish on them over the long term.
Investors are shying away from coronavirus stocks, even though a top investor just bought into this one.
The ARKK ETF has been one of the biggest winners over the past five years. It should continue to prosper, at least until the current tech boom fades.
These three golden eggs could make investors rich.
Two ARK exchange-traded funds run by ETF star Cathie Wood bought nearly 200,000 shares of Teladoc Health,Inc.
The company's earnings outlook isn't nearly as bad as the recent stock price beating suggests.
Both tech-related medical stocks have had a phenomenal past 12 months, with shares rising more than 90%. But only one has a solid chance to continue that level of growth in 2021.
The economy is changing, and these stocks are still a buy after their recent pullbacks.
All three of these stocks have had incredible spikes because of COVID-19. One stock, however, is a safer and stronger long-term investment.
Why this trader is trimming holdings in Teladoc, Fiverr
CNBC's "Halftime Report" team discusses where they are trimming and buying amid today's trading session.
What's the one negative that might keep Teladoc from being a dominant stock?
Right now Teladoc Health is the dominant name in virtual healthcare. Are there any internet companies that might dislodge Teladoc from its leadership position?
Here's the main reason you want to own shares of this virtual medical company.
NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tela...
Teladoc's (TDOC) Q4 earnings result reflects revenue gains, more than offset by flared-up expenses.
Teladoc CEO on fourth-quarter results and 2021 growth forecast for telehealth business
Teladoc reported a 145% increase in quarterly revenue as more people booked virtual doctor visits during the pandemic. The stock was one of the big pandemic winners, though shares have given u...
Moderna, Teladoc Health, and Fulgent Genetics have all spiked a lot higher because of COVID-19. And all three companies have platforms for growth over the next decade.
Any short-term pullback could present a great opportunity to buy these long-term winners.
Shares of Teladoc Health (NYSE:TDOC) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 3.85% over the past year to ($0.27), which mi...
Q4 revenue grows 145% year-over-year to $383.3 million and total visits increase 139% to 3.0 million
Traders are moving on from the telehealth leader's shares. But should they be?
Case Shiller Home Prices Rose Better-Than-Expected In December
These fast-paced companies should run circles around Sundial Growers over the long term.
Investors are questioning if these companies can maintain their growth rates in a post-pandemic world.
Teladoc Health's (TDOC) Q4 earnings are likely to reflect higher visit volumes and subscriptions, along with an increase in marketing expenses.
Successful money managers piled into these fast-paced companies during the fourth quarter.
Each of these innovative companies is expected to at least triple their sales in the next three or four years.
Well Health could become a big name in the healthcare industry.
Residents and those displaced can call 855-225-5032 to access treatment for non-emergency illnesses Residents and those displaced can call 855-225-5032 to access treatment for non-emergency il...
In the latest trading session, Teladoc (TDOC) closed at $287.86, marking a -1.15% move from the previous day.
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
We are glad to announce that we have added Catherine Wood (Trades, Portfolio)'s ARK Investment Management as one of our Premium Gurus.
These virtual care and online pharmacy platforms could make you healthy and wealthy.
Here's the 411 on finding stocks that can yield 1,000% (or greater) returns.
These high-growth companies can run circles around the world's largest cryptocurrency.
Want to play it safe in a volatile market? Go for these three top-notch healthcare picks.
Teladoc (TDOC) closed at $290.43 in the latest trading session, marking a +0.67% move from the prior day.
PURCHASE, NY, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release fourth-quarter and full-year 2...
Some medical stocks gained momentum because of the pandemic, while others focus on high-reward challenges like cancer treatment. The post 7 Healthy Medical Stocks to Buy appeared first on Inve...
The conditions are ripe for an explosive bull market to take shape under the new administration.
My unscientific study proves what I've long believed.
Here's one hybrid health-tech SPAC that's a favorite among Reddit investors.
Hint: Much of a company's success has to do with the experiences and diversity of its leadership.
About TDOC
Teladoc Health provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, expert medical services, behavioral health solutions, guidance and support, and platform and program services. The company's platform enables patients and providers to have an integrated smart user experience through mobile, Web, and... [Read more...]
| Industry Health Information Services | IPO Date Jul 1, 2015 |
| CEO Jason Gorevic | Country United States |
| Stock Exchange NYSE | Ticker Symbol TDOC |
Financial Performance
In 2020, Teladoc Health's revenue was $1.09 billion, an increase of 97.71% compared to the previous year's $553.31 million. Losses were -$485.14 million, 390.7% more than in 2019.
Analyst Forecasts
According to 31 analysts, the average rating for Teladoc Health stock is "Buy." The 12-month stock price forecast is 262.56, which is an increase of 38.42% from the latest price.